Lazertinib
CAS No. 1903008-80-9
Lazertinib ( YH 25448;YH25448;GNS-1480;GNS1480 )
Catalog No. M12983 CAS No. 1903008-80-9
Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 53 | In Stock |
|
5MG | 84 | In Stock |
|
10MG | 138 | In Stock |
|
25MG | 245 | In Stock |
|
50MG | 309 | In Stock |
|
100MG | 447 | In Stock |
|
500MG | 1035 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLazertinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.
-
DescriptionLazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations; shows the beneficial for the NSCLC with brain metastasis.Lung Cancer Phase 2 Clinical
-
SynonymsYH 25448;YH25448;GNS-1480;GNS1480
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR (del19);EGFR (T790M);EGFR (T790M/L858R)
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number1903008-80-9
-
Formula Weight554.66
-
Molecular FormulaC30H34N8O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: Insoluble; Water: Insoluble; DMSO: 10 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESC=CC(NC1=CC(NC2=NC=CC(N3N=C(C4=CC=CC=C4)C(CN(C)C)=C3)=N2)=C(OC)C=C1N5CCOCC5)=O
-
Chemical NameN-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Patent US20160102076 A1.
2.Yun J, et al. Clin Cancer Res. 2019 Jan 22. pii: clincanres.2906.2018. doi: 10.1158/1078-0432.CCR-18-2906.
2.Yun J, et al. Clin Cancer Res. 2019 Jan 22. pii: clincanres.2906.2018. doi: 10.1158/1078-0432.CCR-18-2906.
molnova catalog
related products
-
Genistein
Genistein(NPI 031L), a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.
-
FRAX597
FRAX597 is an effective, ATP-competitive inhibitor of group I PAKs, and for PAK1(IC50=8 nM), PAK2(IC50=13 nM), and PAK3 (IC50=19 nM).
-
Naquotinib
Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.